NCT06418100

Brief Summary

This interventional study aims to learn about the postoperative analgesic efficacy of a new fascial plane block, recto-intercostal fascial plane block, at coronary artery bypass grafting with sternotomy. There will be two groups, one of which will be the control group, and the other will be the study group randomly receiving postoperative recto-intercostal fascial plane block. The main questions it aims to answer are the effect of this new block on postoperative opioid consumption and pain scores. Also, postoperative outcomes related to respiratory ( postoperative oxygenation and atelectasis score), hemodynamic functions ( newly developed arrhythmias), total postanesthesia care unit stay, and hospital stay will be questioned.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable coronary-artery-disease

Timeline
Completed

Started Mar 2024

Shorter than P25 for not_applicable coronary-artery-disease

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 26, 2024

Completed
4 days until next milestone

Study Start

First participant enrolled

March 1, 2024

Completed
3 months until next milestone

First Posted

Study publicly available on registry

May 16, 2024

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
Last Updated

March 19, 2025

Status Verified

March 1, 2025

Enrollment Period

1.2 years

First QC Date

February 26, 2024

Last Update Submit

March 17, 2025

Conditions

Keywords

coronary artery bypass graftingParasternal intercostal plane blockRecto-intercostal fascial plane blockPostoperative analgesia

Outcome Measures

Primary Outcomes (1)

  • Total rescue analgesic

    . From the beginning of acclaimed arousal till the 24th hour, rescue analgesia as tramadol 100 mg (maximum daily dose 400 mg) is applied if NRS over 4 or with the patient's request.

    postoperative 24 hour

Secondary Outcomes (4)

  • intraoperative opioid use

    intraoperative

  • intraoperative hemodynamic change

    at sternotomy

  • postoperative respiratory function

    postoperative 48 hour

  • postoperative arythmias

    postoperative 48 hour

Other Outcomes (1)

  • total hospital stay

    postoperative

Study Arms (2)

The Control

NO INTERVENTION

The participants will have standardized anaesthesia management and receive postoperative rescue analgesia as morphine.

The rectointercostal fascial plane block

EXPERIMENTAL

The participants will receive postoperative recto intercostal fascial plane block, with 20 ml 0,25 bupivacaine bilaterally.

Procedure: The recto intercostal fascial plane block

Interventions

After ensuring aseptic conditions, the high-frequency linear ultrasound probe was used to detect the rectus abdominis muscle and the 6-7th costal cartilage as described by Tulgar et al. After rotating and shifting the transducer, 6-7th costal cartilages, the rectus abdominis muscle, and intercostal muscles between the cartilages were confirmed. The primary investigator (B.C.) directed the needle tip caudad in the cephalic direction in-plainly, and 20 ml 0,25% bupivacaine was injected bilaterally into the plane between the costal cartilage and the rectus abdominis muscle following negative aspiration.

The rectointercostal fascial plane block

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients who will undergo CABG surgery with sternotomy
  • patients who have an American Society of Anesthesiologists (ASA) Physical Status classification of III to IV

You may not qualify if:

  • refusal to participate
  • a history of neurological deficits or neuropathy affecting the thoracal innervation
  • infection at the site of block application
  • allergy to local anesthetics
  • epilepsy or treatment with antipsychotics
  • abuse of alcohol or drugs
  • previous surgery distorting the anatomy of the sternum, thorax or upper abdominal area
  • severe organ dysfunction ( kidney, liver and other); patients who fail at weaning after 12 hours of surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Haseki Training and Research Hospital

Istanbul, Sultangazi, Turkey (Türkiye)

Location

Related Publications (2)

  • Tulgar S, Ciftci B, Ahiskalioglu A, Bilal B, Alver S, Sakul BU, Ansen G, Pence KB, Alici HA. Recto-intercostal fascial plane block: Another novel fascial plane block. J Clin Anesth. 2023 Oct;89:111163. doi: 10.1016/j.jclinane.2023.111163. Epub 2023 Jun 7. No abstract available.

    PMID: 37295124BACKGROUND
  • Chen Y, Li Q, Liao Y, Wang X, Zhan MY, Li YY, Liu GJ, Xiao L. Preemptive deep parasternal intercostal plane block for perioperative analgesia in coronary artery bypass grafting with sternotomy: a randomized, observer-blind, controlled study. Ann Med. 2023;55(2):2302983. doi: 10.1080/07853890.2024.2302983. Epub 2024 Feb 20.

    PMID: 38375661BACKGROUND

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Officials

  • Berna Caliskan

    Haseki Training and Research Hospital Anesthesiology and Reanimation Department

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
The participants under general anaesthesia and the cardiovascular surgeon responsible for the study were blinded to the study groups. This surgeon served as the sole evaluator of postoperative outcomes. Intraoperative results were recorded by the anaesthesia technician, who was present in the operating room and unaware of the block procedures performed. Moreover, the data analysis was conducted before the unblinding of the data.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: prospective, randomized, triple-blind, controlled
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 26, 2024

First Posted

May 16, 2024

Study Start

March 1, 2024

Primary Completion

May 1, 2025

Study Completion

June 1, 2025

Last Updated

March 19, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations